<DOC>
	<DOCNO>NCT01100892</DOCNO>
	<brief_summary>Cystic Fibrosis ( CF ) common life-threatening genetic condition affect Australian child . As well repeat lung infection , child CF develop insulin deficiency eventually diabetes . The CF-IDEA trial ( Cystic Fibrosis - Insulin Deficiency , Early Action ) determine whether start insulin treatment onset diabetes ( earlier current practice ) improve health child CF improve body weight lung function .</brief_summary>
	<brief_title>Cystic Fibrosis - Insulin Deficiency , Early Action</brief_title>
	<detailed_description>As well progressive lung disease , patient Cystic Fibrosis ( CF ) suffer pancreatic destruction , lead slow progressive insulin deficiency . Deficiency insulin , powerful anabolic hormone , cause accelerated decline weight lung function ( important predictor early mortality CF ) . We analyse Oral Glucose Tolerance Tests sample every 30 min define stage CF Insulin Deficiency ( CFID ) early glucose abnormality , CFID1 ( BGmax &gt; =8.2 &lt; 11.1mmol/L ) CFID2 ( BGmax &gt; =11.1 BG120min &lt; 11.1 ) , progress diabetes without fast hyperglycaemia ( CFID3 ) , finally diabetes fast hyperglycaemia ( CFID4 ) . Currently insulin treatment standard CFID3 4 , data show early stage ( CFID1 2 ) also associate decline weight lung function . In CF-IDEA Trial , subject CF age &gt; =5 year early glucose abnormality ( CFID1 2 ) randomise once-daily insulin detemir ( Levemir ) 12 month , observation . We aim determine whether start insulin earlier current practice prevent decline weight lung function , reduce frequency hospitalisation , improve quality life , slow progression CFID category . Our pilot study use once-daily Levemir child CFID1 2 find simple insulin regimen ( rather multiple daily injection ) well accepted patient , minimal hypoglycaemia , result significant weight gain improve lung function ( compare 12 month prior insulin ) . Sample size calculation CF-IDEA Trial base pilot study . When 70-80 % patient complete protocol , study statistician perform interim analysis ( blinded investigator ) check original power calculation . Stages CF Insulin Deficiency : CFID1 Peak BG OGTT &gt; =8.2mmol/L &lt; 11.1mmol/l . CFID2 Peak BG OGTT &gt; =11.1mmol/L 120 minute BG &lt; 11.1 . CFID3 120 minute BG OGTT &gt; =11.1mmol/L . CFID4 Fasting hyperglycemia ( Fasting BG &gt; =7mmol/L ) .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Patients CF age &gt; =5 yr attend one study sit . CFID1 CFID2 ( define BGmax &gt; =8.2 BG120 &lt; 11.1mmol/l OGTT perform within last 6 month , respiratory function stable judge treat respiratory team , take fluoroquinolone antibiotic , take systemic glucocorticoid ) . Cystic Fibrosis Related Diabetes , define CFID3 ( BG120 &gt; 11.1mmol/L ) CFID4 ( fast BG &gt; 7mmol/L ) . Such patient offer insulin treatment standard clinical care . Unstable respiratory disease ( hospital admission treatment respiratory exacerbation within last month ) . Treatment systemic glucocorticoid 1 month duration , within last 12 month .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Pediatrics</keyword>
	<keyword>Pancreas</keyword>
</DOC>